Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:ACB 7 December 2025 - 12 December 2025

Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) Stock Jumps on US Marijuana Rescheduling Headlines: Today’s News, Forecasts, and Analysis (Dec. 12, 2025)

Aurora Cannabis (ACB) jumped about 15% in pre-market trading Friday after reports that President Trump may direct agencies to reclassify marijuana as a Schedule III drug. The White House said no final decisions have been made. Investors responded to the potential for eased penalties and tax burdens. Aurora closed at $4.55 on Dec. 11 and was indicated near $5.30 early Friday.
12 December 2025
Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis (ACB) Stock on December 7, 2025: Australia Deal, Q2 2026 Earnings and What Forecasts Say Next

Aurora Cannabis shares traded near US$4.60 on NASDAQ and C$6.39 on TSX as of early December, valuing the company at about US$260–280 million. The stock remains volatile, with a 34% drop from its February high but up 12–13% over the last 10 sessions. On December 2, Aurora’s MedReleaf Australia signed a distribution deal with Leafio, expanding access to over 4,000 pharmacies nationwide.
7 December 2025
···

Stock Market Today

  • Neo Performance Materials Stock Dips Amid Valuation Debate Following Volatile Trading
    March 20, 2026, 1:59 PM EDT. Neo Performance Materials (TSX:NEO) experienced a steep 14.1% drop in share price in one day and 22.5% over the past week, despite a strong 90-day gain of 27.46% and a 1-year return exceeding 118%. The Toronto-based company, active in rare earth materials across multiple regions, sees divided views on valuation. A popular market narrative values shares at CA$25.33, suggesting a nearly 20% undervaluation against Friday's CA$20.47 close. However, a discounted cash flow (DCF) analysis counters this with a much lower fair value of CA$13.16, indicating the stock could be overvalued. The stock's future hinges on execution at a new Estonian sintered magnet plant and demand from Europe's automotive sector. Investors face a clear dilemma amid this volatility and contrasting valuation models.
Go toTop